Crovalimab,Eculizumab
Roche,AstraZeneca
['obinu', 'commodore ', 'rova,(-approval),(-microvascular)', 'commodore 1', 'roche,(-broche),(-rocheter)']
roche presents p-iii studies (commodore 1 &amp; 2) results of crovalimab for the treatment of paroxysmal nocturnal haemoglobinuria at eha 2023 #clinicaltrials 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds